Serum transforming growth factor β (TGF-β) is associated with body mass index in healthy women

Acta Endocrinologica

Volumn 9, Issue 3, 2013, Pages 361-368

  Farhangi, M Abbasalizad ^a   Saboor Yaraghi, A A ^b   Eshraghian, M ^c   Ostadrahimi, A ^d   Keshavarz, S A ^e  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Department of Cellular and Molecular Nutrition   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

BMI; Fat mass; Obesity; Transforming growth factor

Indexed keywords

EID: 84883186853     PISSN: 18410987     EISSN: None     Source Type: Journal    
DOI: 10.4183/aeb.2013.361     Document Type: Article

References (30)

1. Torun D, Ozelsancak R, Turan I, Micozkadioglu I H, Sezer S, Ozdemir F. The relationship between obesity and transforming growth factor beta on renal damage in essential hypertension. Int Heart J. 2007; 48(6): 733-741.
2. Li M, Flavell R. TGF-β: a master of all T cell trades. Cell 2008; 134(3): 392-404.
3. Pfeiffer A, Middelberg K, Drewes C, Schatz H. Elevated plasma levels of transforming growth factor-β in NIDDM. Diabetes Care. 1996; 19(10): 1113-1117.
4. Ziyadeh FN, Sharma K, Wolf G, Ericksen M. Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming growth factor-β. J Clin Invest. 1994; 93(2): 536-542.
5. Sharma K, Ziyadeh FN. Hyperglycemia and diabetic kidney disease: The case for transforming growth factor-B as a key mediator. Diabetes Care. 44(10): 1139-1146.
6. Samad F, Yamamoto K, Pandey M, Loskutoff D. Elevated expression of transforming growth factor-β in adipose tissue from obese mice. Mol Med. 1997; 3(1): 37-48.
7. Alessi M, Bastelica D, Morange P, Berthet B, Leduc I, Verdier M, Geel O, Juhan-Vague I. Plasminogen activator inhibitor 1, transforming growth factor-β1, and BMI are closely associated in human adipose tissue during morbid obesity. Diabetes Care. 2000; 49(6): 1374-1380.
8. Tarantino G, Conca P, Riccio A, Tarantino M, Minno M, Chianese D, Pasanisi F, Contaldo, Scopacasa F, Capone D. Enhanced serum concentrations of transforming growth factorbeta1 in simple fatty liver: is it really benign? J Transl Med. 2008; 6: 72-80.
9. Kinugasa A, Tsunamoto K, Furukawa N, Sawada T, Kusunoki T, Shimada N. Fatty liver and its fibrous changes found in simple obesity of children. J Pediatr Gastroenterol Nutr. 1984; 3(3): 408-414.
10. Ikai E, Honda R, Yamada Y. Serum gammaglutamyl transpeptidase level and blood pressure in nondrinkers: a possible pathogenetic role of fatty liver in obesity-related hypertension. J Hum Hypertens. 1994; 8(2): 95-100.
11. Falck-Ytter Y, Younossi ZM, Marchesini G, McCullough A. Clinical features and natural history of nonalcoholic steatosis syndromes. Semin Liver Dis 2001; 21(1): 17-26.
12. Bugianesi E, Zannoni C, Vanni E, Marzocchi R, Marchesini G. Non-alcoholic fatty liver and insulin resistance: a cause-effect relationship. Digest Liver Dis. 2004; 36(3): 165-173.
13. Friedewald W, Levy R, Fredrickson D. Estimation of the concentration of LDL cholesterol in plasma without use of preparative ultracentrifuge. Clin Chem. 1972; 18(6): 499-502.
14. Farhangi MA, Keshavarz SA, Eshraghian MR, Ostadrahimi A, Saboor-Yaraghi AA. White blood cell count in women: relation to inflammatory biomarkers, haematological profiles, visceral adiposity, and other cardiovascular risk factors. J Health Popul Nutr. 2013; 31(1): 58-64.
15. Kopelman P. Obesity as a medical problem. Nature 2000; 404 (6778): 635-643.
16. Elian VI, Cucu I, Cheta D, Serafinceanu C. Weight loss in young obese subjects improves lipids and adipokines levels and reduces arterial stiffness. Acta Endocrinologica (Buc). 2013; 9(1): 79-86.
17. Visscher T, Seidell J. The public health impact of obesity. Annu Rev Public Health. 2001; 22: 355-375.
18. Monteiro C, Moura E, Conde W, Popkin B. Socioeconomic status and obesity in adult populations of developing countries: a review. Bull World Health Organ. 2004; 82(12) 940-946.
19. Prentice A. The emerging epidemic of obesity in developing countries. Int J Epidemiol. 2006; 35(1): 93-99.
20. Bortell R, Van Wijnen AJ, Ramsey-Ewing AL, Stein GS, Stein JL. Differential regulation of H4 histone gene expression in 3T3-LI pre-adipocytes during arrest of proliferation following contact inhibition or differentiation and its modulation by TGF beta. J Cell Biochem. 1992; 50(1): 62-72.
21. Jeoung DI, Tang B, Sonenberg M. Mitogenic response to TGF-beta in 3T3-F442A cells. Biochem Biophys Res Commun. 1995; 216(3): 964-969.
22. Butterwith SC, Goddard C. Regulation of DNA synthesis in chicken adipocyte precursor cells by insulin-like growth factors, plateletderived growth factor and transforming growth factor-beta. J Endocrinol. 1991; 131(1): 203-209.
23. Petruschke T, Rohrig K, Hauner H. Transforming growth factor beta (TGF-β) inhibits the differentiation of human adipocyte precursor cells in primary culture. Int J Obes Relat Metab Disord. 1994; 18(4): 532-536.
24. Lichiardopol R, Florentiu A, Radoi V. Body composition and the metabolic impact of weight excess in patients with type 1 and type 2 diabetes mellitus. Acta Endocrinologica (Buc). 2010; 6(4): 493-506.
25. Valean C, Ichim G, Tatar S, Samasca G, Leucuta A, Nanulescu M. Prevalence of metabolic syndrome and serum profile of adipokines (Leptin and Adiponectin) in children with overweight or obesity. Acta Endocrinologica (Buc). 2010; 6(3): 343-354.
26. Juhan-Vague I, Pike S, Alessi M, Jespesen J, Haverkate F, Thomspson SG. Fibrinolytic factor and the risk of myocardial infarction of sudden death in patients with angina pectoris. Thromb Haemost. Thromb Haemost. 1996; 94 (9): 2057-2063.
27. Roberts AB, Sporn MB. Peptide growth factors and their receptors I. Handb Exp Pharmacol. Springer, Berlin 1990; 419-472.
28. Battegay EJ, Raines EW, Seifert RA, Bowenpope DF, Ross R. TGF-β induces bimodal proliferation of connective tissue cell via complex control of an autocrine PDGF loop. Cell. 1990; 63 (3): 515-524.
29. Sepuveda-Flores RN, Vera-Cabrera L, Flores-Gutierrez JP, Maldonado-Garza H, Salinas-Garza R, Zorrilla-Blanco P, Bosques-Padilla FJ. Obesity-related non-alcoholic steatohepatitis and TGF-beta1 serum levels in relation to morbid obesity. Ann Hepatol. 2002; 1(1): 36-39.
30. Tominaga K, Kurata JH, Chen YK, Fujimoto E, Miyagawa S, Abe I, Kusano Y. Prevalence of fatty liver in Japanese children and relationship to obesity. Digest Dis Sci. 1995; 40 (9): 2002-2009.